ReviewBMJ global health2023

Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation.

Mathew Mercuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.